79 patents
Utility
Compound for Use In and Methods of Treatment of Fibrotic Diseases
21 Dec 23
Silke Wilma HUETTNER
Filed: 22 Nov 21
Utility
Salts and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
21 Dec 23
Nicolas Luc SABOURAULT, Carla DE FAVERI, Ahmad SHEIKH, Piet WIGERINCK
Filed: 25 Apr 23
Utility
Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
5 Oct 23
Steven Emiel VAN DER PLAS, Oscar MAMMOLITI, Sebastien Laurent Xavier MARTINA, Pieter Isabelle Roger CLAES, Ghjuvanni Petru Diunisu COTI, Denis Maurice ANNOOT, Miriam LÓPEZ RAMOS, René Alexandre GALIEN, David AMANTINI, Réginald Christophe Xavier BRYS
Filed: 27 Dec 22
Utility
Substantially Pure Clarithromycin 9-OXIME and Its Preparation Thereof
10 Aug 23
Sudhir NAMBIAR, Rakesh Ramesh GANORKAR, Kiran CHAUDHARI, Anil GOHAR, Deeksha SINGH, Patrick CLAERHOUT STIJN POL
Filed: 27 Oct 20
Utility
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
8 Aug 23
Franck Laurent Brebion, Luke Jonathan Alvey, David Amantini, Frédéric André De Ceuninck, Pierre Marc Marie Joseph Deprez, Romain Luc Marie Gosmini, Hélène Marie Jary, Christophe Peixoto, Iuliana Ecaterina Pop-Botez, Marie Laurence Claire Varin
Filed: 5 Jan 21
Utility
Compounds and Pharmaceutical Compositions Thereof for Use In the Treatment of Fibrotic Diseases
3 Aug 23
The present invention relates to compounds useful in the prophylaxis and/or treatment of one or more fibrotic diseases.
Reginald Christophe Xavier BRYS, Philippe CLÉMENT-LACROIX, Steve Irma Joel DE VOS, Laurent Raymond Maurice SANIERE
Filed: 4 Nov 22
Utility
Treatment of Atopic Dermatitis
29 Jun 23
The present invention provides a pharmaceutical composition comprising an antibody for antibody fragment specific for IL-17C, in particular MOR106 for use in the treatment of atopic dermatitis and related conditions wherein the antibody is administered to patients at dosages that are beneficial in a clinical setting.
Stefan Haertle, Tim Van Kaem, Frederic Paul Vanhoutte
Filed: 25 Sep 18
Utility
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
31 Jan 23
Steven Emiel Van Der Plas, Oscar Mammoliti, Sébastien Laurent Xavier Martina, Pieter Isabelle Roger Claes, Ghjuvanni Petru Diunisu Coti, Denis Maurice Annoot, Miriam López Ramos, René Alexandre Galien, David Amantini, Reginald Christophe Xavier Brys
Filed: 11 Oct 18
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
26 Jan 23
Nicolas DESROY, Bertrand HECKMANN, Reginald Christophe Xavier BRYS, Agnès Marie JONCOUR, Christophe PEIXOTO, Xavier Marie BOCK
Filed: 18 Jun 21
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
22 Dec 22
David AMANTINI, Reginald Christophe Xavier BRYS, Denis BUCHER, Steve Irma Joel DE VOS, Nicolas DESROY, Agnès Marie JONCOUR, Christophe PEIXOTO, Taoues TEMAL-LAÏB, Amynata TIRERA
Filed: 29 May 19
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
27 Oct 22
Luke Jonathan ALVEY, Denis BUCHER, Nicolas DESROY, Hélène Marie JARY, Christophe PEIXOTO, Taoues TEMAL-LAÏB, Amynata TIRERA, Florence Marie-Emilie BONNATERRE, Béranger DUTHION
Filed: 25 May 20
Utility
Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
27 Oct 22
Luke Jonathan ALVEY, Denis Maurice ANNOOT, Florence Marie-Emilie BONNATERRE, Denis BUCHER, Béranger DUTHION, Hélène Marie JARY, Christophe PEIXOTO, Taoues TEMAL-LAIB, Amynata TIRERA, Nicolas DESROY
Filed: 13 Apr 22
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
22 Sep 22
Oscar MAMMOLITI, Réginald Christophe Xavier BRYS, Gregory John Robert NEWSOME, Marielle Gilles BABEL
Filed: 24 Mar 20
Utility
Prodrug Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
8 Sep 22
The present invention relates to prodrug compounds and their use in the treatment of Cystic Fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Didier Philippe Robert Schils, Sam Bob Corveleyn, Herman Augustinus De Kock, Matthew Beau Dufek
Filed: 27 May 22
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
28 Jul 22
Taoues TEMAL-LAÏB
Filed: 25 May 20
Utility
Novel Dihydropyrimidinoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders.
21 Jul 22
Frédéric Gilbert LABÉGUÈRE, Gregory John Robert NEWSOME, Luke Jonathan ALVEY, Laurent Raymond Maurice SANIÈRE, Stephen Robert FLETCHER
Filed: 12 Nov 21
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
14 Jul 22
Oscar MAMMOLITI, Hélène Marie JARY, Mislav ORSULIC, Denana VRBAN, Marijana KOMAC, Réginald Christophe Xavier BRYS, Rhalid AKKARI
Filed: 24 Mar 20
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Kidney Diseases
30 Jun 22
Katja Els CONRATH, Reginald Christophe Xavier BRYS, Thierry Jean-Claude Marie CHRISTOPHE, Ronald VAN DER GEEST
Filed: 21 Apr 20
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
23 Jun 22
Oscar MAMMOLITI, Réginald Christophe Xavier BRYS, Gregory John Robert NEWSOME, Marielle Gilles BABEL
Filed: 24 Mar 20
Utility
Pyrrolopyrimidine and Pyrrolopyridine Derivatives
2 Jun 22
David AMANTINI, Milan MESIC, Gordon SAXTY, Tanja POLJAK, Ines VUJASINOVIC, Dinko ZIHER, David WITTY, Karl Richard GIBSON
Filed: 3 Sep 21